Stock Information
Urogen Pharma Ltd (URGN)
Ticker Symbol: URGN
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $1,294.95 mil
Piotroski score: 5
PE Ratio: N/A
EPS (TTM): -2.7452
Revenue (TTM): $2.80 M
Dividend Yield: N/A%
ROE: -204.47%
Latest News
-
Urogen Pharma (NASDAQ:URGN) Nears 52-Week High on Minervini Trend Template and High Growth Momentum Screen
Thu, Jul 9, 2026 11:20 AM
-
UroGen Pharma Receives FDA IND Application Clearance For Its Investigational Oncolytic Virus UGN-501
Wed, Jul 8, 2026 8:01 AM
Key Financials
Financial data not available